# Phase I Trial: T4 Immunotherapy of Head and Neck Cancer

> **NCT01818323** · PHASE1 · UNKNOWN · sponsor: **King's College London** · enrollment: 30 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **OTHER:** Intra-tumoral T4 immunotherapy

## Key facts

- **NCT ID:** NCT01818323
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2024-12
- **Final completion:** 2025-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01818323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01818323, "Phase I Trial: T4 Immunotherapy of Head and Neck Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01818323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*